Jan. 28, 2026 — Corify Care has announced a major development in cardiac electrophysiology with the publication of its ...
Jan. 28, 2026 — Imperative Care has announced the commercial launch and first patient cases of the new Zoom 4S Catheter ...
Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Jan. 27, 2026 — BURL Concepts, a private company developing a rapid, automated and affordable test for evaluating ...
Jan. 27, 2026 — Cytokinetics, Inc. has announced that Myqorzo (aficamten) is now available for prescription in 5 mg, 10 ...
Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Jan. 27, 2026 — Robocath has launched the world’s first FIH (First-In-Human) clinical study evaluating its new robotic ...
Jan. 26, 2026 — AISAP, a provider of AI point-of-care diagnostics, has published a new clinical study in the peer ...
Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...
Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...
Jan. 20, 2026 — Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, has expanded ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
On Feb. 19, at 7 p.m. eastern time, Cleerly will present a live webinar on “Women's Heart Health: Uncovering Hidden ...
Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...
Jan. 16, 2026 — MemorialCare Heart & Vascular Institute has launched the FDA-approved Symplicity Renal Denervation (RDN) ...
January 29, 2026
